Breaking News
January 19, 2018 - ‘You’re Old and You Need Tests’: What We Heard This Week
January 19, 2018 - Egg-preserving hysterectomy raises heart risks later: study
January 19, 2018 - GA-map Dysbiosis Test identifies IBS patients who respond to FODMAP diet, study shows
January 19, 2018 - Study explores mortality and health-related habits in former elite athletes and their brothers
January 19, 2018 - New biodegradable sensors could assist doctors
January 19, 2018 - Modular gene enhancers may be suitable target in treatment of blood cancer
January 18, 2018 - New precision medicine trial for metastatic pancreatic cancer
January 18, 2018 - Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients
January 18, 2018 - Pre-Existing Patient-Valve Mismatch Trips Up ViV Implant
January 18, 2018 - Adolescents: health risks and solutions
January 18, 2018 - US woman delivers baby from embryo frozen for 24 years
January 18, 2018 - Study identifies new target for treatment of depression
January 18, 2018 - LJI study reveals key player that promotes skin inflammation in atopic dermatitis
January 18, 2018 - Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations
January 18, 2018 - Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla (AG200-15) for the Prevention of Pregnancy
January 18, 2018 - Gene Therapy for Inherited Retinal Dystrophy Gets FDA Clearance
January 18, 2018 - Researchers identify a new chemical pathway that helps the brain detect sweet, savory and bitter flavors
January 18, 2018 - IBV develops platform that helps companies to diagnose wellbeing of their workforce
January 18, 2018 - Study to test new precision medicine approach for metastatic pancreatic cancer
January 18, 2018 - World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows
January 18, 2018 - FDA Approves New Indication for Gilotrif (afatinib) in EGFR Mutation-Positive NSCLC
January 18, 2018 - Oncologists Dish on Top Issues for 2018
January 18, 2018 - Researchers identify new potential drug target for Huntington’s disease
January 18, 2018 - Metrohm USA welcomes employees to new headquarters in Florida
January 18, 2018 - Human waste remains main source of fecal pollution in the river Danube
January 18, 2018 - Expert discusses how to stay healthy during flu season
January 18, 2018 - New biomaterials-based system improves T-cell production
January 18, 2018 - Novel gene expression analysis technique can accurately and quickly measure RNA
January 18, 2018 - Grandparents Help Shape Kids’ Views on Aging
January 18, 2018 - Absolutely Zero Stent Thrombosis at 5 Years With Bioabsorbable MiStent
January 18, 2018 - Safe Sleep for Babies | VitalSigns
January 18, 2018 - Pfizer to launch own little white pill
January 18, 2018 - Aged garlic extract may help obese people fight against inflammation, study shows
January 18, 2018 - Sex steroid hormone fluctuations may have direct effects on eye physiology and AMD
January 18, 2018 - Patients with monoclonal gammopathy at risk of developing cancer even after 30 years
January 18, 2018 - Researchers reveal potential of multivalent antibodies for HIV prevention, treatment and cure
January 18, 2018 - Dying cancer patients receiving assisted hydration live longer
January 18, 2018 - Potential male birth control pill could be developed from arrow poison
January 18, 2018 - Research reveals cost-effectiveness of whole-population screening for breast, ovarian cancer gene mutations
January 18, 2018 - Genes involved in spinal cord repair of lamprey also present in mammals, study reveals
January 18, 2018 - Researchers unravel key molecular mechanism of autoimmune and inflammatory diseases
January 18, 2018 - The State of the Drug Discovery Nation Unveiled as New Report Provides Vital Insights for the Development of New Medicines
January 18, 2018 - Dutch Study Links Implants to Increased Breast-ALCL Risk
January 18, 2018 - Five addiction experts weigh in on future of opioid crisis. Their forecast: grim
January 18, 2018 - EXD2 enzyme facilitates protein production in mitochondria
January 18, 2018 - Kessler Foundation wins $735,000 grant for training rehabilitation researchers
January 18, 2018 - Researchers find new way to halt growth of breast cancer cells
January 18, 2018 - Cantex Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation Has Been Granted to CX-01 for Treatment of Acute Myeloid Leukemia
January 18, 2018 - Civilians Now Getting Flu-Like Illness Afflicting Troops
January 18, 2018 - Discovery brings stem cell therapy for eye disease closer to the clinic
January 18, 2018 - Guts of surfers more likely to be colonized by antibiotic-resistant bacteria, study reveals
January 18, 2018 - Bacteria linked to periodontitis may play role in onset of cancer
January 18, 2018 - Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea
January 18, 2018 - Early Menarche, Menopause Tied to Higher CVD Risk
January 18, 2018 - Pioneering new technique could boost understanding of causes of heart disease
January 18, 2018 - New brain imaging techniques show how infants’ brains process ‘touch’
January 18, 2018 - GSK Receives FDA Approval for Expanded Indication for Fluarix Quadrivalent (Influenza Vaccine) for Persons 6 Months and Older
January 18, 2018 - Blood Markers Point to Maladaptive LV Remodeling
January 18, 2018 - Effect of gut bacteria on specific immune cells underlies persistent liver inflammation
January 18, 2018 - Study reveals new diabetes gene in families with rare blood sugar conditions
January 18, 2018 - Fewer Hospitals Closed After Obamacare Expanded Medicaid
January 18, 2018 - At-Home Breath Training Improves Asthma Quality of Life
January 18, 2018 - Obesity can add five weeks of asthma symptoms per year in preschoolers
January 18, 2018 - Neuronal loss is very limited in Alzheimer’s disease, shows new study
January 18, 2018 - A new strategy proposed for drug discovery
January 17, 2018 - Lactation May Lower T2D Risk in Younger Women
January 17, 2018 - New Atopic Dermatitis Yardstick provides practical guidance and management insights
January 17, 2018 - New biodegradable pressure sensor could help monitor serious health conditions
January 17, 2018 - HSS orders Sectra’s 3D pre-operative planning solution for improving patient outcomes
January 17, 2018 - Study identifies six new genes regions associated with diabetes
January 17, 2018 - Women do not receive timely diagnosis for heart disease
January 17, 2018 - AbbVie’s Upadacitinib Shows Positive Results as Monotherapy in Phase 3 Rheumatoid Arthritis Study, Meeting All Primary and Key Secondary Endpoints
January 17, 2018 - Should President Trump’s Physical Include a Cognitive Screen?
January 17, 2018 - Could gene therapy someday eliminate HIV?
January 17, 2018 - Researchers identify new anti-inflammatory drug target
January 17, 2018 - Loxo Oncology Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancers
January 17, 2018 - Trunk Imaging Tied to Higher Nephrectomy Risk
January 17, 2018 - Campaigners incensed at failings in Africa AIDS war
January 17, 2018 - Research opens door to development of new treatment for type 2 diabetes
January 17, 2018 - Uniqsis’ novel reactor system for continuous flow synthesis
Cocaine use during adolescence is even more harmful than during adulthood

Cocaine use during adolescence is even more harmful than during adulthood

image_pdfDownload PDFimage_print
A pile of cocaine hydrochloride. Credit: DEA Drug Enforcement Agency, public domain

People who begin using cocaine during adolescence exhibit more significant cognitive deficits than people who begin using the drug in adulthood. Long suspected by experts in neuroscience, the hypothesis received objective confirmation by researchers working at the University of São Paulo’s Medical School (FM-USP) in Brazil.

When scientists compared the two groups of cocaine users, they observed pronounced differences, mainly in specific neuropsychological functions such as sustained attention (required for performing long tasks, such as completing a questionnaire), working memory (used in specific actions, for example, a waiter remembering the order of each person at a table) and declarative memory (storing and retrieving data after a period of time).

They also found that among early-onset users, the concurrent consumption of cannabis and alcohol was 50 percent and 30 percent more frequent, respectively, compared with late-onset users, defined as those who began using cocaine at or over the age of 18. The complete findings of the research project were published in the journal Addictive Behaviors.

“Adolescence is considered one of the key stages of brain development when surplus synapses are eliminated and the structures essential to adulthood are selected and refined. Drug use in this stage can impair the brain programming process and lead to the loss of important connections,” said Paulo Jannuzzi Cunha, a professor at FM-USP and principal investigator for the project.

Differentiated Methodology

According to Cunha, one of the novel aspects of the research project was the measurement of cognitive functions during controlled abstinence. “Many studies of this kind assess outpatients without any possibility of knowing whether they’ll use drugs when they go home,” he said. “In our case, however, all participants were hospital inpatients. We can therefore be sure the findings didn’t reflect acute effects of cocaine or other substances.”

The sample contained 103 cocaine-dependent patients, 52 of whom were early-onset users who had begun using the drug before they were 18, while 51 were late-onset users who began when they were 18 or older. All individuals were evaluated after at least a week of abstinence. The absence of cocaine metabolites was verified by toxicological urine tests. A third group of 63 people with no history of psychoactive substance use served as the control.

The participants’ ages ranged from 20 to 35. The proportions of men and women were similar. One of the early-onset users had begun consuming cocaine at age 12.

“Data in the scientific literature shows that a brain region called the prefrontal cortex continues to develop until age 25. This region relates to what are known as executive functions such as planning, decision making, inhibitory control, attention and working memory. We therefore decided to investigate whether these functions were more impaired in early-onset users,” said psychologist Bruna Mayara Lopes, first author of the article.

The evaluation involved a number of tests, including the Frontal Assessment Battery (FAB), Stroop Color Word Test (SCWT), Controlled Oral Word Association Test (COWAT), Wisconsin Card Sorting Test (WCST), Rey Osterrieth Complex Figure Test (ROCFT) and Iowa Gambling Task (IGT). The use of alcohol and other drugs was assessed using the Addiction Severity Index (ASI-6).

“Basically, we presented the participants with a task they had to complete, such as repeating a sequence of numbers in reverse order or reproducing a figure from memory about 30 minutes after observing it,” Lopes said.

When they compared late-onset users with the control group and adjusted the results for variables such as age and intelligence quotient (IQ), the only difference the researchers found was in divided attention, which relates to the ability to perform multiple tasks at the same time.

In a study underway at USP’s Neuroimaging Laboratory (LIM-21), the researchers are now seeking to correlate the cognitive profile observed in the two groups of cocaine-dependent patients with decision making and resting-state brain activity using functional magnetic resonance imaging (fMRI). Studies of brain structure and correlations with levels of a protein known as BDNF (brain-derived neurotrophic factor) will also be performed using these findings.

“We’re measuring such variables as prefrontal cortex volume and white matter integrity. We’ll be able to disclose some of our findings shortly,” said Priscila Dib Gonçalves, a co-author of the article.

White matter, found in the deeper tissues of the brain, contains axons connecting grey matter, which is where all synapses are located.

According to Gonçalves, a higher probability of cognitive impairment due to early-onset drug use was previously observed in a study involving 104 chronic cannabis users. This study, published in 2011 in the British Journal of Psychiatry, was conducted at the Federal University of São Paulo (UNIFESP) by Maria Alice Fontes. It found that people who began smoking marijuana before age 15 underperformed late-onset users in tests that assessed executive functions.

For Gonçalves, both studies indicate the need to develop more effective prevention strategies and programs targeting adolescents. “We live in a society that associates recreation with the use of psychoactive substances, and this is an important cultural aspect,” she said. “One way to raise awareness of the risks could be to hold workshops with students, who should be called on to play a leading role in this awareness-raising process, rather than being passive recipients of information.” For Cunha, the results also show that patients with severe cognitive deficits need intense multidisciplinary treatment, including medication as well as therapy.


Explore further:
Cocaine users present alterations in the function and structures of the brain

More information:
Bruna Mayara Lopes et al, Distinct cognitive performance and patterns of drug use among early and late onset cocaine users, Addictive Behaviors (2017). DOI: 10.1016/j.addbeh.2017.04.013

Journal reference:
British Journal of Psychiatry

Provided by:
FAPESP

Tagged with:

About author

Related Articles